Introduction Plan
Claim: Gene therapy is a good medical benefit plan because it could prevent hereditary illness and disease, eventually eradicate such diseases, and allow individuals that would be born with hereditary diseases lead better, more normal lives.
Audience: Physicians, anti-gene therapy communities, parents of diseased children, said diseased children
Research and Drafting
I will be exploring the benefits and risks of gene therapy, ethical issues, and citing previous research.
List of works for potential use:
Bergeson, Emilie R. "The Ethics of Gene Therapy." NDSU - North Dakota State University. 1997. Web. 14 Nov. 2011. <http://www.ndsu.edu/pubweb/~mcclean/plsc431/students/bergeson.htm>.
Bushnelle, E., E. Hertz, D. Hubbard, K. Saylor, and A. Slyker. "Technology of Gene Therapy." Macalester College: Private Liberal Arts College. Web. 14 Nov. 2011. <http://www.macalester.edu/~montgomery/GeneTherapy.htm>.
Twyman, Richard. "Gene Therapy | The Human Genome." In the Genome | The Human Genome. 27 Aug. 2002. Web. 14 Nov. 2011. <http://genome.wellcome.ac.uk/doc_WTD020911.html>.
Weiss, Rick. "Washingtonpost.com: Gene Therapy." The Washington Post: National, World & D.C. Area News and Headlines - The Washington Post. 22 Mar. 1998. Web. 14 Nov. 2011. <http://www.washingtonpost.com/wp-srv/national/science/genetherapy/unborn.htm>.
Whara, Chris. "Human Gene Therapy." NDSU - North Dakota State University. 1999. Web. 14 Nov. 2011. <http://www.ndsu.edu/pubweb/~mcclean/plsc431/students99/wharam.htm>.
Organizing Paragraphs
Introduction
Body 1
Body 2
Body 3
Body 4
Body 5
Body 6
Closing